Orazio Caffo

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

Giampietro Gasparini, Noel Weidner, Pierantonio Bevilacqua et al. · Journal of Clinical Oncology · 1994 · 468 citations

Medicine, Oncology, Pathology +14

Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial—FIRSTANA

Stéphane Oudard, Karim Fizazi, Lisa Sengeløv et al. · Journal of Clinical Oncology · 2017 · 356 citations

Medicine, Pharmacology, Pharmacotherapy +17

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Kim N., Dana E. Rathkopf, Matthew R. Smith et al. · Journal of Clinical Oncology · 2023 · 319 citations · Full text

Medicine, Oncology, Urology +17

High syndecan‐1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis

Mattia Barbareschi, Patrick Maisonneuve, D Aldovini et al. · Cancer · 2003 · 238 citations

Veterinary Medicine, Molecular Biology, Oncology +17

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone

Cristian Lolli, Orazio Caffo, Emanuela Scarpi et al. · Frontiers in Pharmacology · 2016 · 203 citations · Full text

Medicine, Oncology, Pharmacology +15